Updated on November 22, 2023

·

Created on August 27, 2015

SEA-PAP High Oscillation Continuous Positive Airway Pressure Device

Upcoming Update

A respiratory support device for infants.

Developed By
  1. The NeoRest team at the Seattle Children’s Hopsital
Content Partners
  1. World Health Organization (WHO)

Author

Product Description

The Seattle Children’s Hospital High Oscillation Continuous Positive Airway Pressure (Sea-PAP) Device is a respiratory support technology for infants. The NeoRest Team claims that Sea-PAP improves upon conventional bCPAP by more consistently producing a range of oscillations thought to improve lung function and make it easier for an infant to breathe.

Target Regions

Africa, Central Asia, East Asia, North Asia, South America, South Asia, Southeast Asia

Target SDGs

SDG 3: Good Health and Well-Being

Target Users (Target Impact Group)

Community, Small and Medium-sized Enterprises

Distributors / Implementing Organizations

The NeoRest Team is in the process of finalizing the Sea-PAP device design, identifying manufacturers to produce the device and preparing to conduct clinical trials. It is not being distributed widely at this time.

Manufacturing/Building Method

The main Sea-PAP device body will be mass produced. The unit can be assembled on-site with a small tool kit of supplies including a continuous air supply, a breathing circuit tube, a tube for the nose and water.

Intellectural Property Type

Other

User Provision Model

Unknown

Distributions to Date Status

Prototype device which has not been distributed at scale.

Design Specifications

The Sea-PAP is intended to provide continuous positive airway pressure (CPAP) to spontaneously breathing neonates and infants, up to weights of 10 kg, requiring respiratory support due to conditions associated with prematurity, such as Respiratory Distress Syndrome, or other conditions where CPAP is required and/or prescribed by a physician.Sea-PAP works similarly to conventional Bubble CPAP (bCPAP) devices in providing a continuous flow of air via tubes inserted in an infant's nostrils. The Sea-PAP is comprised of two key elements; a water container and a tube inserted into the water. The Water Reservoir contains the water and has a lid permanently attached to help prevent splashing and spillages. The lid has an integrated Water Level Adjustment Port, to allow a clinician to adjust the water level in the Reservoir, if necessary, without disconnecting the breathing circuit. The tube is comprised of a Funnel-Swivel that is permanently attached to Bubble Tube. The Funnel-Swivel helps prevent spillages when filling the Water Reservoir initially and can rotate to help reduce tension that may build up in the expiratory limb of the breathing circuit. The expiratory end of the patient's breathing circuit, distal to the patient, is inserted into the center of the Funnel-Swivel. A Bubble Tube Lock mechanism is used to ensure the depth of the tube in the water does not change unintentionally. The gas bubbling out of the end of the Tube creates air pressure oscillations in the breathing circuit. For the Sea-PAP device the breathing circuit tube is placed in water at a 135 degree slope, which creates fluctuations in the positive airway pressure and keep the lungs open, lessening the work required from respiratory muscles and making it easier for the infant to breathe.

Product Schematics

Technical Support

N/A

Replacement Components

Unknown

Lifecycle

The breathing and nose tubes can be used multiple times if sterilized. Disposable units can be used, however require a robust consumables supply chain.

Manufacturer Specified Performance Parameters

Unknown

Vetted Performance Status

Unknown

Safety

Unknown

Complementary Technical Systems

The Hansen Ventilator - a separate respiratory device - can be used in conjunction to treat even more premature infants with respiratory distress.

Academic Research and References

Compliance with regulations

In October 2013, Sea-PAP received clearance from the Food and Drug Administration for use and distribution in the U.S.

Evaluation methods

The Seattle-PAP Bubble Nasal CPAP and Work of Breathing clinical trial is currently underway.

Other Information

Unknown

Leave a Reply

Explore similar solutions

Agriculture

November 24, 2023

Pumani Bubble Continuous Positive Airway Pressure (bCPAP) Device

Read Solution

Implemented by

Hadleigh Health Technologies, and Rice 360

Agriculture

February 20, 2024

Arktek Passive Vaccine Storage Device

Read Solution

Implemented by

Intellectual Ventures Lab

Agriculture

February 21, 2024

Brilliance Phototherapy Device

Read Solution

Implemented by

Equalize Health

Agriculture

March 10, 2024

DDG Rapid Assessment of Infectious Diseases (RAID) Device

Read Solution

Implemented by

Disease Diagnostic Group

Agriculture

January 3, 2024

Lotus Water Chlorine Dosing Device

Read Solution

Implemented by

Stanford Researchers and the International Centre for Diarrhoeal Disease Research, Bangladesh

Agriculture

February 5, 2024

Prepex Circumcision Device

Read Solution

Implemented by

Circ MedTech

Agriculture

December 12, 2023

Sohum Hearing Screening Device

Read Solution

Implemented by

Sohum Innovation lab

Agriculture

December 19, 2023

Star ID device

Read Solution

Implemented by

Star Syringe

Agriculture

September 26, 2024

Odon Device

Read Solution

Implemented by

Jorge Odón

Agriculture

February 26, 2024

Gazelle Diagnostic Device

Read Solution

Implemented by

Hemex Health

All Solutions

Contribute to E4C's Library of Breakthrough Sustainable Development Technology Solutions

Suggest A Solution

Get more information about Solutions Library and its features.

Learn More

Have thoughts on how we can improve?

Give Us Feedback

Join a global community of changemakers.

Become A Member